Certain types of breast implants are associated with a rare type of T-cell lymphoma.
Summary
Breast Implant Associated Anaplastic Large Cell Lymphoma (BIA ALCL) is a rare T-cell lymphoma that can develop in patients who have undergone breast implant reconstruction. It is most associated with textured implants. This type of lymphoma tends to form in the scar tissue and fluid surrounding a breast implant. In rare cases, the lymphoma spreads throughout the body before detection. While the FDA considers the risk of BIA ALCL to be low, it is a serious condition that can lead to death.
Symptoms of BIA ALCL include persistent swelling and the development of a mass or pain around the implant. If you are experiencing any of these symptoms or other changes, it is important to check in with your plastic surgeon to assess the tissue surrounding the implant. BIA ALCL on average occurs 7-9 years after implant placement, though earlier cases are reported. Any history of textured implant placement is important to note with your surgeon.
The types of textured implants believed to be associated with BIA ALCL are rarely used now. However, if you underwent implant breast reconstruction before 2019, or have ever had a textured implant, speak to your plastic surgeon about the type of implants you received and monitor accordingly. While the FDA does not currently recommend implant or capsule removal in asymptomatic patients, it is important to be mindful of how the implants feel moving forward.